EXPLORE THE SCIENCE
A Copper-Amyloid Reaction Was Reversed in Real Time TL;DR: Fluorescence anisotropy let researchers watch copper-driven amyloid-beta aggregation form and reverse, with Ni-bme-dach selectively restoring monomer-like behavior while EDTA acted broadly. Key Finding…
Read article
Immature Neurons Linked to Alzheimer’s Resilience TL;DR: A 2026 Cell Stem Cell study used single-nucleus RNA sequencing of aged human hippocampus tissue and found rare immature neurons in healthy, Alzheimer’s, and dementia-resilient brains. The important signa…
Read article
Early Locus Coeruleus Axon Loss May Explain Smell Loss in Alzheimer’s TL;DR: Alzheimer’s-model mice lost noradrenergic locus coeruleus axons in the olfactory bulb before major plaque buildup, took 60% longer to find buried food, and improved when microglial ph…
Read article
SuperAgers Reveal Brain Biology of Preserved Memory TL;DR: Octogenarians who recall words like 50-year-olds carry a distinct brain profile: preserved cortical volume, a cingulate cortex thicker than younger adults, larger entorhinal neurons, fewer inflammatory…
Read article
Lifetime Cognitive Enrichment Delayed Alzheimer’s Dementia TL;DR: In 1,939 Rush Memory and Aging Project participants, higher lifetime cognitive enrichment was linked to 38% lower Alzheimer’s dementia hazard and about 5 years later dementia onset. Key Findings…
Read article
Dopamine Disruption May Start Alzheimer’s Memory Failure TL;DR: In an Alzheimer’s mouse model, early memory failure tracked a broken dopamine signal into the lateral entorhinal cortex, and both optogenetic dopamine reactivation and L-DOPA partially restored le…
Read article
Alzheimer’s Treatment Needs More Than Amyloid TL;DR: A 2026 review in Science China Life Sciences argues that amyloid-beta antibodies such as lecanemab and donanemab are important progress, but Alzheimer’s treatment cannot stop at amyloid. The disease also inv…
Read article
Broken Blood Vessels May Drive Alzheimer’s Decline TL;DR: A new study reveals that impaired cerebrovascular function—the brain’s ability to regulate blood flow—correlates strongly with Alzheimer’s symptoms, offering a potential non-invasive way to detect early…
Read article
How Lecanemab Clears Brain Amyloid: The Microglia Key TL;DR: Lecanemab, the first Alzheimer’s antibody to slow cognitive decline, works by activating immune cells called microglia through a specific immune signaling pathway, with the molecule SPP1/osteopontin…
Read article
Cell-Type Gene Networks Reveal Hidden Causes of Alzheimer’s TL;DR: Researchers mapped how genes are regulated differently across six brain cell types in Alzheimer’s disease, discovering that excitatory neurons drive the most extensive regulatory disruptions—an…
Read article